Healthcare Sales & Marketing Network News: KALYDECO

Searching News Database: KALYDECO

HSMN NewsFeed - 19 May 2022
Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair
Biopharmaceuticals Oncology Personnel

HSMN NewsFeed - 23 Jul 2019
Proteostasis Therapeutics Announces Management Changes and Appointments
Biopharmaceuticals Personnel

HSMN NewsFeed - 20 Jul 2015
aTyr Pharma Announces Transitions In Clinical Development & Operations
Biopharmaceuticals Personnel

HSMN NewsFeed - 6 Aug 2014
Akebia Therapeutics Announces Expansion of Management Team
Biopharmaceuticals Personnel

HSMN NewsFeed - 27 Jun 2014
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor) in Eight Non-G551D Gating Mutations
Biopharmaceuticals Regulatory

HSMN NewsFeed - 4 Sep 2012
Vertex Announces Appointment of Stuart A. Arbuckle as Chief Commercial Officer
Biopharmaceuticals Personnel

HSMN NewsFeed - 25 May 2012
Vertex Receives European CHMP Positive Opinion for KALYDECO(TM) (ivacaftor), the First Medicine to Treat the Underlying Cause of Cystic Fibrosis
Biopharmaceuticals Regulatory

Return to NewsFeed

FindReps - Find Great Medical Independent Sales Reps without recruiter fees.

FindReps - available on the Apple App Store for iPhone and iPad.